AYLA logo

Ayala Pharmaceuticals (AYLA) Cash From Operations

Annual CFO

-$38.36 M
-$10.81 M-39.27%

December 31, 2021


Summary


Performance

AYLA Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherAYLAcash flowmetrics:

Quarterly CFO

-$9.34 M
-$2.31 M-32.92%

September 30, 2022


Summary


Performance

AYLA Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherAYLAcash flowmetrics:

TTM CFO

-$34.13 M
+$32.00 K+0.09%

September 30, 2022


Summary


Performance

AYLA TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherAYLAcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

AYLA Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-39.3%+0.3%+9.1%
3 y3 years-502.0%-81.2%-128.3%
5 y5 years-502.0%-162.1%-128.3%

AYLA Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low+32.9%+7.0%at high+13.4%
5 y5-year+156.6%at low+152.7%+23.7%+128.3%+13.4%
alltimeall time+502.0%at low+267.2%+23.7%+858.3%+13.4%

Ayala Pharmaceuticals Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2022
-
-$9.34 M(+32.9%)
-$34.13 M(-0.1%)
Jun 2022
-
-$7.02 M(-29.7%)
-$34.17 M(-11.7%)
Mar 2022
-
-$9.98 M(+28.1%)
-$38.69 M(+0.9%)
Dec 2021
-$38.36 M(+39.3%)
-$7.79 M(-16.8%)
-$38.36 M(+2.2%)
Sep 2021
-
-$9.37 M(-18.9%)
-$37.54 M(+1.4%)
Jun 2021
-
-$11.55 M(+19.7%)
-$37.03 M(+20.2%)
Mar 2021
-
-$9.65 M(+38.4%)
-$30.80 M(+11.8%)
Dec 2020
-$27.54 M
-$6.97 M(-21.3%)
-$27.54 M(+13.5%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$8.86 M(+66.7%)
-$24.26 M(+18.1%)
Jun 2020
-
-$5.32 M(-16.8%)
-$20.55 M(+15.6%)
Mar 2020
-
-$6.39 M(+73.0%)
-$17.78 M(+18.9%)
Dec 2019
-$14.95 M(+134.7%)
-$3.69 M(-28.3%)
-$14.95 M(+32.8%)
Sep 2019
-
-$5.15 M(+102.7%)
-$11.26 M(+84.4%)
Jun 2019
-
-$2.54 M(-28.6%)
-$6.10 M(+71.4%)
Mar 2019
-
-$3.56 M
-$3.56 M
Dec 2018
-$6.37 M
-
-

FAQ

  • What is Ayala Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for Ayala Pharmaceuticals?
  • What is Ayala Pharmaceuticals annual CFO year-on-year change?
  • What is Ayala Pharmaceuticals quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Ayala Pharmaceuticals?
  • What is Ayala Pharmaceuticals quarterly CFO year-on-year change?
  • What is Ayala Pharmaceuticals TTM cash flow from operations?
  • What is the all time high TTM CFO for Ayala Pharmaceuticals?
  • What is Ayala Pharmaceuticals TTM CFO year-on-year change?

What is Ayala Pharmaceuticals annual cash flow from operations?

The current annual CFO of AYLA is -$38.36 M

What is the all time high annual CFO for Ayala Pharmaceuticals?

Ayala Pharmaceuticals all-time high annual cash flow from operations is -$6.37 M

What is Ayala Pharmaceuticals annual CFO year-on-year change?

Over the past year, AYLA annual cash flow from operations has changed by -$10.81 M (-39.27%)

What is Ayala Pharmaceuticals quarterly cash flow from operations?

The current quarterly CFO of AYLA is -$9.34 M

What is the all time high quarterly CFO for Ayala Pharmaceuticals?

Ayala Pharmaceuticals all-time high quarterly cash flow from operations is -$2.54 M

What is Ayala Pharmaceuticals quarterly CFO year-on-year change?

Over the past year, AYLA quarterly cash flow from operations has changed by +$32.00 K (+0.34%)

What is Ayala Pharmaceuticals TTM cash flow from operations?

The current TTM CFO of AYLA is -$34.13 M

What is the all time high TTM CFO for Ayala Pharmaceuticals?

Ayala Pharmaceuticals all-time high TTM cash flow from operations is -$3.56 M

What is Ayala Pharmaceuticals TTM CFO year-on-year change?

Over the past year, AYLA TTM cash flow from operations has changed by +$3.40 M (+9.07%)